Background: Long-term anti-cytomegalovirus (CMV) treatments in immunocompromised
patients are hampered by resistance to antiviral drugs. Longitudinal changes in the …

Antiviral susceptibilities to ganciclovir, foscarnet, and cidofovir and sequencing of UL97 and
DNA polymerase were done on 23 cytomegalovirus (CMV) isolates from 10 …

Resistance of cytomegalovirus (CMV) to antiviral agents is a well-recognized phenomenon
that has been observed in the laboratory and in the clinical setting. Infections caused by …

Long term therapies needed for managing human cytomegalovirus (HCMV) infections in
immunosupressed patients provided the background for the emergence of the resistance to …

A patient with AIDS and cytomegalovirus (CMV) retinitis received ganciclovir and foscarnet
for 20 and 5 months, respectively, with evidence of periodic disease progression. After this …

Background: Treatment of cytomegalovirus (CMV) diseases with protracted administration of
ganciclovir can promote the development of resistant CMV that is associated with a poor …

Phenotypically, ganciclovir‐resistant human cytomegalovirus strains could be selected by
aciclovir as effectively as by ganciclovir in vitro. Three clinical human cytomegalovirus …

ABSTRACT A new recombinant phenotyping method was developed for the analysis of drug
resistance mutations in human cytomegalovirus (CMV). CMV strain T2211 was derived from …

Ganciclovir susceptibilities and UL97 sequences were analyzed in 20 cytomegalovirus
(CMV) isolates recovered from 15 bone marrow transplant recipients with active CMV …

BACKGROUND: The emergence of human cytomegalovirus (CMV) antiviral resistance plays
a significant role in disease progression in immunocompromised patients who have …